Mirae Asset Global Investments Co., Ltd. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$405,578
-49.2%
676,189
+10.2%
0.00%
-50.0%
Q2 2023$797,842
-13.7%
613,724
+16.8%
0.00%0.0%
Q1 2023$924,493
-40.8%
525,280
+5.6%
0.00%
-50.0%
Q4 2022$1,561,541
-49.9%
497,306
-21.8%
0.00%
-50.0%
Q3 2022$3,115,000
+35.9%
635,794
+14.8%
0.01%
+33.3%
Q2 2022$2,292,000
-48.7%
553,727
-28.0%
0.01%
+20.0%
Q1 2022$4,466,000
+30.8%
768,786
+68.9%
0.01%
-28.6%
Q4 2021$3,415,000
+5.4%
455,277
+26.6%
0.01%
-12.5%
Q3 2021$3,240,000
-10.7%
359,678
+18.7%
0.01%
-20.0%
Q2 2021$3,628,000
+10.1%
303,102
+15.2%
0.01%
-9.1%
Q1 2021$3,296,000
+46.9%
263,002
+82.9%
0.01%
+37.5%
Q4 2020$2,244,000
+114.5%
143,834
+29.9%
0.01%
+60.0%
Q3 2020$1,046,000
+55.7%
110,715
+47.7%
0.01%
+25.0%
Q2 2020$672,000
+119.6%
74,968
+56.0%
0.00%
+100.0%
Q1 2020$306,000
-14.5%
48,066
+12.3%
0.00%0.0%
Q4 2019$358,000
+21.8%
42,809
+31.7%
0.00%0.0%
Q3 2019$294,00032,4970.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders